Relating to gender-affirming treatment; declaring an emergency.

HB 3338 requires Oregon's Health Evidence Review Commission to evaluate gender-affirming treatments - including puberty blockers, hormone therapy, and specific surgeries - by August 2025, developing evidence-based guidelines for health providers, patients, and insurers. The commission must assess safety, efficacy, and evidence quality for these treatments across age groups, with a final report due by September 2026. The bill declares an emergency to expedite this process and expires on January 2, 2027. It directly affects healthcare providers, patients seeking gender-affirming care, and health insurers in Oregon by mandating a formal review of treatment protocols.